Abstract
Chronic human lung allograft rejection (BOS) limits long-term survival following human lung transplantation (LT). However, the pathogenesis of BOS remains unclear. Here we characterized the cytokine response and HLA class-II alloimmunity that may predispose to BOS.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
